CDNA Caredx, Inc.
$26.20 +11.89%
Healthcare · Services-Medical Laboratories
Caredx, Inc. (CDNA) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $1.4 billion. Shares last traded at $26.20, near their 52-week high. Over the past year the stock is up 34.2%. Net profit margin is -5.6%, above the peer median of -8.0%. Revenue grew 13.8% year over year.
Market Cap
$1.4B
Shares Out
51.7M
EPS (TTM)
$-0.81
P/E Ratio
—
P/S Ratio
3.56
P/B Ratio
4.32
Dividend / Share
—
Dividend Yield
—
52-Week High
$26.50
52-Week Low
$10.99
Volume
42,559
Avg Vol (3m)
40,734.571
Performance
1W
+10.83%
1M
+27.74%
3M
+49.03%
6M
+35.33%
YTD
+36.81%
1Y
+34.15%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
70.19
SMA (50)
$21.36
SMA (200)
$18.35
Price vs SMA50
+22.63%
Price vs SMA200
+42.79%
ATR (14)
$1.46
Financials
Revenue
$380M
Net Income
$-21M
Gross Margin
21.5%
Operating Margin
-8.1%
Net Margin
-5.6%
Return on Equity
-6.8%
Return on Assets
-5.2%
Current Ratio
3.40
Debt / Equity
0.00
Revenue Growth (YoY)
+13.8%
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.05 | 2026-04-28 |
| FY 2025 | $-0.40 | 2026-02-25 |
| Q3 2025 | $-0.32 | 2025-11-04 |
| Q2 2025 | $-0.35 | 2025-08-06 |
| Q1 2026 | $-0.19 | 2026-04-28 |
| FY 2025 | $0.93 | 2026-02-25 |
Services-Medical Laboratories peers
CDNA vs 14 industry peers (Services-Medical Laboratories), by market cap.
P/S vs peers
3.56 / 1.94 med
+84% premium
Net margin vs peers
-5.6% / -8.0% med
above median
1–14 of 14
| NTRA | Natera, Inc. | $33.1B | -159.23 | 14.37 | -9.0% | +2.17% |
| DGX | Quest Diagnostics | $21.6B | 21.76 | 1.96 | 9.0% | -1.44% |
| LH | Labcorp | $21.0B | 23.93 | 1.50 | 6.3% | -1.40% |
| GH | Guardant Health, Inc. | $17.5B | -41.98 | 17.80 | -42.4% | +2.06% |
| CAI | Caris Life Sciences, Inc. | $5.2B | — | — | — | +3.41% |
| BLLN | Billiontoone, Inc. | $4.8B | — | — | — | +5.38% |
| VCYT | Veracyte, Inc. | $4.3B | 64.47 | 8.28 | 12.8% | +4.50% |
| CELC | Celcuity Inc. | $4.3B | -24.15 | — | — | -0.45% |
| RDNT | Radnet, Inc. | $4.2B | -226.56 | 2.07 | -0.9% | +1.83% |
| GRAL | Grail, Inc. | $2.7B | — | — | — | +7.35% |
| FTRE | Fortrea Holdings Inc. | $1.4B | — | — | — | -0.20% |
| CDNA | Caredx, Inc. | $1.4B | -63.38 | 3.56 | -5.6% | +11.89% |
| PSNL | Personalis, Inc. | $1.1B | -13.55 | — | — | +8.29% |
| LMRI | Lumexa Imaging Holdings, Inc. | $907M | — | — | — | +7.76% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.